PTCT
PTC Therapeutics Inc
$64.84
0.99 (1.50%) Today
0.12 (0.19%) After-hours
— up— down
Market Cap
$5.42B+7.1%
Revenue (TTM)
$909.32M-42.8%
Net Income (TTM)
$-48,592,110
$-48,592,110EPS (TTM)
-0.59
-0.59Shares Out
82.95M
82.95MP/E Ratio
8.06
8.06Forward P/E
30.25
30.25Open
$64.96
$64.96Previous Close
$65.95
$65.95Day Range
$64.28 – $65.97
$64.28 – $65.9752-Week Range
$60.80 – $90.87
$60.80 – $90.87Beta
0.50
0.50Volume
899.42K
899.42KAvg Volume
1.52M
1.52MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout PTCT
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.